Chorionic villus sampling (CVS) is a prenatal diagnostic procedure introduced in 1968, involving the removal of chorionic villi from the placenta for genetic testing, typically performed between 10 and 12 weeks of gestation. The procedure carries risks such as miscarriage and infection, but is considered reliable, with a success rate that has improved over the years. Indications for CVS include abnormal ultrasound findings, family history of genetic disorders, and advanced maternal age.